Danaher Corporation

DHR · Healthcare · · USD

207.66 USD

0.00 (-1.60%)

● Updated 2026-09-07 20:34 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score BUY Long-term (Investment)

/ 100

Technical 50

Trend & RS 63

Momentum 63

Fundamental 85

Macro 64

Liquidity 49

Component	Score	Weight
Technical	50.0	10%
Trend & RS	62.9	10%
Momentum	63.0	5%
Fundamental	84.8	40%
Macro	64.4	15%
Liquidity	49.0	20%

Trade Setup

Entry	207.66
Stop Loss	195.08 (6.1%)
Target 1 (1:1)	220.24 (+6.1%)
Target 2 (2:1)	232.82 (+12.1%)

ATR(14)	6.29 (3.0%)
Risk per Share	12.58
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	45.5	-0.18
Momentum	63.0	+0.52
Quality	40.0	-0.40
Composite	49.5

Quality Scores

Piotroski F-Score 7 /9 — Strong

✓ ✓ ✗ ✗ ✓ ✓ ✓ ✓ ✓

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score 4.59 — Safe Zone

Distress <1.81Grey 1.81–2.99>2.99 Safe

Valuation vs Peers Fair Value

Metric	Stock	Sector	vs Peers
P/E Ratio	37.0	22.0	+68% above
P/B Ratio	2.8	4.0	Below
Dividend Yield	77.0%	1.5%	Above avg

Comparing against Healthcare median multiples.

Intrinsic Value (DCF) Significantly Overvalued

Intrinsic Value

80.49

Market Price

207.66

Upside

-61.2%

Margin of Safety	-158.0%
Stage 1 PV (5yr FCF)	14,318,909,279
Terminal Value PV	42,261,010,272
Total Enterprise Value	56,579,919,551

Assumptions

Base FCF	3,155,001,410
Growth Rate (5yr)	5.5%
Terminal Growth	2.5%
Discount Rate (WACC)	9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.5%

Recommended Size

44.4%

Full Kelly

22.2%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 68/100. Estimated win rate 60%, avg win 9.1%, avg loss 3.6%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary BUY

Bullish Signals

Bearish Signals

50.47

RSI(14)

3.0899

MACD

Relative Strength (RS) WEAK RS

/ 99

RS Rating

O'Neil filter: <80

RS vs SPY	↑ RISING (+8.2% vs SPY 3M)
RS vs Sector	OUTPERFORMING (Healthcare)
RS New High	No (10d since high)
Sector Outperformance	+5.1% (3M)

RS Line — stock / SPY (90 bars)

← older newer →

RS vs SPY 50-day SMA of RS

WEAK RS: Underperformer — the stock is lagging the market. Avoid until RS trend reverses upward.

Technical Indicators

Indicator	Value	Signal
Rsi	50.47	NEUTRAL
Macd	3.0899	BEARISH
Ma Cross	201.63 / 202.27	DEATH CROSS
Trend Short		ABOVE SMA50
Trend Long		ABOVE SMA200
Bollinger		MIDDLE
Volume	0.93x	NORMAL

Key Levels

Level	Price
52-Week High	242.80
Bollinger Upper	221.33
SMA(200)	202.27
SMA(50)	201.63
SMA(20)	210.23
Current Price	207.66
Bollinger Lower	199.14
52-Week Low	160.93
ATR(14)	6.29

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

MARKUP Confidence

100%

Acc: 0.0 | Dist: 0.0 | Markup: 2.0 | Markdown: 0.0

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-08-31	Normal	1.16x	Normal bar — no special VSA pattern
2026-09-01	Normal	1.01x	Normal bar — no special VSA pattern
2026-09-02	Normal	0.95x	Normal bar — no special VSA pattern
2026-09-03	Normal	0.78x	Normal bar — no special VSA pattern
2026-09-04	Normal	0.93x	Normal bar — no special VSA pattern

Ichimoku Cloud NEUTRAL

Line	Value	Status
Tenkan-sen (9)	211.90	Above Kijun
Kijun-sen (26)	206.64	Base line
Senkou A	209.27	Leading span A
Senkou B	193.21	Leading span B
Cloud	193.21 – 209.27	Bullish (Green)
Price vs Cloud	207.66	Inside Cloud
Chikou Span	194.98	Bullish
Alignment Score	3/4	NEUTRAL